Visioneering Technologies, Inc. (VTI.AX)

0.1450 -0.0300 (-17.14%) At close: 04:10PM AEST

Visioneering Technologies, Inc.

30 Mansell Court
Suite 215
Alpharetta, GA 30076
United States
844-884-5367
https://www.vtivision.com

Sector(s): Healthcare
Industry: Medical Devices
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Brian D. Lane CPA	Chief Operating & Chief Financial Officer	446.02k	N/A	1962
Dr. Kuang-Mon Tuan FAAO, Ph.D.	Chief Medical Officer	508.58k	N/A	N/A
Dr. Juan Carlos Aragon	CEO & Executive Director	N/A	N/A	N/A
Dr. Richard A. Griffin	Founder & Medical Adviser	N/A	N/A	N/A
Ms. Layna L. Mendlinger	Global Head of Marketing	N/A	N/A	N/A
Ms. Leanne Ralph AAICD, ACIS, BBus	Company Secretary	N/A	N/A	N/A

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Visioneering Technologies, Inc., a medical device company, engages in the design, manufacture, sale, and distribution of contact lenses in North America, Europe, and the Asia-Pacific. Its flagship product is NaturalVue, a multifocal one-day contact lens for adults with presbyopia and children with myopia. The company was incorporated in 2008 and is headquartered in Alpharetta, Georgia.

Corporate Governance

Visioneering Technologies, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.